Zylox-Tonbridge Medical Technology Co., Ltd. Stock price

Equities

2190

CNE100004JD2

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
9.69 HKD 0.00% Intraday chart for Zylox-Tonbridge Medical Technology Co., Ltd. +1.79% -22.11%

Financials

Sales 2023 528M 73.02M 571M Sales 2024 * 756M 105M 819M Capitalization 2.93B 406M 3.17B
Net income 2023 -78M -10.79M -84.44M Net income 2024 * 72M 9.96M 77.94M EV / Sales 2023 7.02 x
Net cash position 2023 * 1.05B 145M 1.13B Net cash position 2024 * 994M 138M 1.08B EV / Sales 2024 * 2.56 x
P/E ratio 2023
-47.1 x
P/E ratio 2024 *
40.7 x
Employees 765
Yield 2023 *
-
Yield 2024 *
-
Free-Float 32.23%
More Fundamentals * Assessed data
Dynamic Chart
Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket MT
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker MT
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd CI
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd. CI
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE CI
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7% MT
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System CI
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System CI
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device MT
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU MT
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany CI
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval CI
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter MT
More news
1 week+1.79%
Current month+4.64%
1 month-0.51%
3 months-21.47%
6 months+19.93%
Current year-22.11%
More quotes
1 week
9.26
Extreme 9.26
9.93
1 month
9.21
Extreme 9.21
10.70
Current year
9.21
Extreme 9.21
12.58
1 year
7.20
Extreme 7.2
14.66
3 years
7.20
Extreme 7.2
60.80
5 years
7.20
Extreme 7.2
60.80
10 years
7.20
Extreme 7.2
60.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 12-11-05
Director of Finance/CFO 46 20-12-31
Chief Tech/Sci/R&D Officer 58 18-12-31
Members of the board TitleAgeSince
Director/Board Member 53 21-03-01
Director/Board Member 52 15-10-31
Director/Board Member 56 20-10-12
More insiders
Date Price Change Volume
24-03-28 9.69 0.00% 201 000
24-03-27 9.69 +0.31% 207,000
24-03-26 9.66 -0.41% 174,500
24-03-25 9.7 +0.52% 268,500
24-03-22 9.65 +1.37% 622,629

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.951 CNY
Average target price
14.07 CNY
Spread / Average Target
+57.21%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Zylox-Tonbridge Medical Technology Co., Ltd. - Hong Kong S.E.